Balyasny Asset Management’s Sage Therapeutics SAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $13.8M | Buy |
|
|||||
|
2025
Q1 | $904K | Buy |
|
|||||
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $1.32M | Sell |
|
|||||
|
2022
Q2 | $10.8M | Buy |
|
|||||
|
2022
Q1 | $638K | Buy |
|
|||||
|
2021
Q4 | – | Hold |
|
|||||
|
2021
Q3 | – | Hold |
|
|||||
|
2020
Q4 | – | Sell |
|
|||||
|
2020
Q3 | $8.7M | Buy |
|
|||||
|
2020
Q2 | – | Sell |
|
|||||
|
2020
Q1 | $547K | Sell |
|
|||||
|
2019
Q4 | $11M | Buy |
|
|||||
|
2019
Q1 | – | Hold |
|
|||||
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $10.7M | Buy |
|
|||||
|
2018
Q2 | $2.23M | Sell |
|
|||||
|
2018
Q1 | $38.4M | Sell |
|
|||||
|
2017
Q4 | $43M | Sell |
|
|||||
|
2017
Q3 | $22.4M | Buy |
|
|||||
|
2017
Q2 | $15.2M | Sell |
|
|||||
|
2017
Q1 | $18.2M | Sell |
|
|||||
|
2016
Q4 | $19.3M | Buy |
|
|||||
|
2016
Q3 | $10.6M | Buy |
|
|||||
|
2016
Q2 | $3.37M | Buy |
|
|||||
|
2016
Q1 | – | Sell |
|
|||||
|
2015
Q4 | $1.53M | Buy |
|